When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Mylan N.V. (NASDAQ:MYL) and Biocon Biologics India, a subsidiary of Biocon Ltd. (OTC:BCNQY)announce the U.S. launch of Semglee (insulin glargine injection) in vial and pre-filled pen to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes. It is not recommended for the treatment of diabetic ketoacidosis.
More news on: Mylan N.V., Biocon Ltd. ADR, Healthcare stocks news,